CAPTRUST Financial Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,258
| Closed | -$1.02M | – | 2284 |
|
|
2023
Q4 | $1.02M | Sell |
12,258
-2,948
| -19% | -$246K | ﹤0.01% | 1254 |
|
|
2023
Q3 | $448K | Buy |
15,206
+5,035
| +50% | +$148K | ﹤0.01% | 1711 |
|
|
2023
Q2 | $332K | Sell |
10,171
-18
| -0.2% | -$587 | ﹤0.01% | 1897 |
|
|
2023
Q1 | $359K | Sell |
10,189
-687
| -6% | -$24.2K | ﹤0.01% | 1611 |
|
|
2022
Q4 | $498K | Buy |
10,876
+6,699
| +160% | +$307K | ﹤0.01% | 1331 |
|
|
2022
Q3 | $202K | Buy |
4,177
+304
| +8% | +$14.7K | ﹤0.01% | 1816 |
|
|
2022
Q2 | $152K | Sell |
3,873
-37
| -0.9% | -$1.45K | ﹤0.01% | 1894 |
|
|
2022
Q1 | $144K | Buy |
3,910
+1,735
| +80% | +$63.9K | ﹤0.01% | 1973 |
|
|
2021
Q4 | $99K | Buy |
2,175
+18
| +0.8% | +$819 | ﹤0.01% | 2174 |
|
|
2021
Q3 | $77K | Buy |
2,157
+43
| +2% | +$1.54K | ﹤0.01% | 2279 |
|
|
2021
Q2 | $42K | Sell |
2,114
-17
| -0.8% | -$338 | ﹤0.01% | 2623 |
|
|
2021
Q1 | $50K | Buy |
2,131
+1,991
| +1,422% | +$46.7K | ﹤0.01% | 2425 |
|
|
2020
Q4 | $3K | Sell |
140
-260
| -65% | -$5.57K | ﹤0.01% | 2986 |
|
|
2020
Q3 | $9K | Buy |
+400
| New | +$9K | ﹤0.01% | 2319 |
|